Yuki Kageyama to B7-H1 Antigen
This is a "connection" page, showing publications Yuki Kageyama has written about B7-H1 Antigen.
Connection Strength
0.262
-
STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-?-induced Apoptosis in Urothelial Cancer. Anticancer Res. 2024 May; 44(5):1925-1930.
Score: 0.212
-
Efficacy and Safety of Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Interim Analysis from a Multicenter, Open-label, Prospective Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2023 11 01; 117(3):644-651.
Score: 0.050